20.11.2014 • News

Moberg Pharma appoints new US General Manager

Moberg Pharma has appointed Jeff Vernimb as General Manager for its US operations and a member of Moberg's Management Team, effective from December 15, 2014. Jeff Vernimb brings more than 25 years of experience in consumer health products marketing and sales across multi-national and smaller entrepreneurial businesses.

Prior to his position with Moberg, Jeff Vernimb was Vice President of Sales and a member of the Senior Management Team with Insight Pharmaceuticals. In addition to his position at Insight, he has held senior level positions at Dynova Laboratories, Cardinal Health, Novartis Consumer and Pfizer/Warner Lambert. His experience includes extensive brand management, Rx to OTC switch and customer marketing roles. He started his career in Sales with The Mennen Company.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.